The aim of the clinical practice set is to provide a list of suitable instruments to measure health domains in clinical practice. Because there are different requirements for disease monitoring in practice compared to trials, unlike the core outcome set for trials there is no limit on the number of domains or instruments to measure each domain in the clinical practice set.
The process for agreeing the clinical practice set generally follows the same as for trials i.e. identifying all instruments, then assessing their measurement properties and feasibility for use in clinical practice. All suitable instruments will be listed and clinicians can then choose their preferred instrument(s) to measure any particular domain. In 2017, a survey was carried out of the HOME members to prioritise domains for the clinical practice set.
The HOME VI and HOME VIII meetings achieved consensus on instruments for assessing patient reported symptoms in clinical practice.
Recommended instruments are:
PO-SCORAD
POEM
The HOME VIII meeting (Online, October 2020) achieved consensus on instruments for assessing disease control in clinical practice.
Recap of atopic eczema (RECAP)Atopic dermatitis control tool (ADCT)
Work ongoing
Consensus statement: Jacobson ME et al, 2024
Eczema Area and Severity Index (EASI)
Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) - Link coming soon
Investigator's Global Assessment multiplied by or measured concurrently with a body surface area measure (scale provisional) - Link coming soon
Centre of Evidence Based Dermatology University of Nottingham King's Meadow Campus Lenton Lane, Nottingham NG7 2NR, UK
Telephone: +44 115 8232435 Fax: +44 115 8468618 Email: HOME@nottingham.ac.uk
Browser does not support script.